Publications by authors named "Kent Chee-Keen Woo"
Article Synopsis
- Early diagnosis of Severe Combined Immunodeficiency (SCID) through newborn screening (NBS) can improve survival rates and reduce healthcare costs, but it's not yet implemented in Malaysia.
- A structured interview with 13 experts revealed challenges such as a low ratio of immunologists to patients and limited public awareness about SCID.
- Ongoing initiatives aim to overcome these barriers and develop SCID NBS in Malaysia, with recommendations for government action and increased stakeholder engagement.
Background: Food allergy (FA), which is a condition that has no effective cure and can result in severe life-threatening allergic reactions, remains a global public health concern; however, little is known about how FAs are currently managed in the Asia-Pacific region.
Objective: The main objective of this survey was to evaluate the epidemiology of FA, as well as the availability of resources and practices for management of FA and anaphylaxis by health care providers across Asia.
Methods: From June 2022 to September 2022, a questionnaire-based survey comprising 66 questions was electronically sent to member societies of the Asia Pacific Association of Allergy Asthma and Clinical Immunology by using Survey Monkey.
Allergic rhinitis (AR) is an IgE-mediated inflammatory disease of the upper airway. AR affects the patients' quality of life, is a known risk factor for asthma and a socio-economic burden. Allergen-specific immunotherapy (AIT), comprising sublingual immunotherapy (SLIT) and subcutaneous immunotherapy (SCIT), involves administering increasing doses of the causative allergen to induce clinical and immunologic tolerance to the allergens.
View Article and Find Full Text PDFArticle Synopsis
- The management of allergic rhinitis (AR) aims for effective symptom control to improve patients' quality of life, primarily through medication.
- There are knowledge gaps among physicians regarding pharmacotherapy use, especially in primary care, and uncertainty about new combination therapies in secondary care.
- To address these issues, a consensus statement has been created to enhance existing guidelines for the rational use of pharmacotherapy in both primary and secondary healthcare settings.
The milk fat globule membrane (MFGM) has been recognized as a milk component for more than 60 years, but its exact benefits remain unknown. Research on human MFGM has revealed that the membrane holds a host of bioactive components with potential benefits for the brain-immune-gut (BiG) axis in early life. Gangliosides and sphingomyelin, components within the MFGM, have been included in infant formulas for many years.
View Article and Find Full Text PDF